Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
305 USD | -0.22% | -0.27% | +5.90% |
Jun. 07 | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
Jun. 06 | Transcript : Amgen Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 09:00 AM |
ETFs positioned on Amgen Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.84% | 0 M€ | 0.00% | - | |
7.63% | 0 M€ | 0.00% | - | |
5.08% | 113 M€ | +14.28% | - | |
3.71% | 21 M€ | +8.41% | - | |
3.24% | 1 M€ | +0.84% | - | |
2.61% | 1 M€ | +2.21% | - | |
1.75% | 4,592 M€ | -.--% | ||
1.73% | 9 M€ | -4.31% | - | |
1.67% | 9 M€ | -.--% | - | |
1.65% | 7 M€ | +5.01% | ||
1.55% | 779 M€ | +4.17% | ||
1.37% | 2 M€ | +20.44% | - | |
1.31% | 5 M€ | -72.95% | - | |
1.29% | 3 M€ | 0.00% | - | |
1.19% | 20 M€ | 0.00% | - | |
1.04% | 3,859 M€ | +18.82% | - | |
1.04% | 469 M€ | -2.05% | ||
1.04% | 1,060 M€ | +3.54% | ||
0.88% | 2 M€ | +9.08% | ||
0.77% | 277 M€ | +3.69% | - | |
0.75% | 7 M€ | +0.11% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.90% | 164B | |
+45.82% | 754B | |
+40.95% | 630B | |
-6.16% | 352B | |
+19.86% | 331B | |
+9.32% | 298B | |
+18.45% | 250B | |
+11.88% | 217B | |
-0.78% | 216B | |
-0.73% | 163B |
- Stock Market
- Equities
- AMGN Stock
- Funds and ETFs Amgen Inc.